NCT00902655View on ClinicalTrials.gov

Desmopressin in the Treatment of Mixed Nocturia With Nocturnal Polyuria and Low Nocturnal Bladder Capacity

PHASE4CompletedINTERVENTIONAL

Enrollment

103

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions

Nocturia

Interventions

DRUG

Desmopressin

Desmopressin 0.1,0.2 or 0.4 mg once daily for 3-weeks of dose titration phase and 4-weeks of treatment phase

Trial Locations (6)

Unknown

Keimyung University School of Medicine, Daegu

College of Medicine Inha University, Inchon

Pusan National University Hospital, Pusan

Asan Medical Center, Seoul

Korea University Anam Hospital, Seoul

Seoul National University College of Medicine, Seoul

All Listed Sponsors

lead

Samsung Medical Center

OTHER

NCT00902655 - Desmopressin in the Treatment of Mixed Nocturia With Nocturnal Polyuria and Low Nocturnal Bladder Capacity | Biotech Hunter | Biotech Hunter